3 Things About Viatris That Smart Investors Know
As one of the world's largest manufacturers of generic medicines, Viatris (NASDAQ: VTRS) is a company that's appealing to investors of all stripes. With its massive portfolio of therapies and biosimilars, this business is willing to enter generic markets of practically any size all over the globe.
But given that it's unprofitable and heavily indebted, it simply isn't very impressive at first glance, which raises the question of why smart investors would approach it at all. Let's examine three tidbits that explain why this stock is worth talking about as an investment.
Image source: Getty Images.
Source Fool.com
